Abiopharma

🔍 Niderno Allison G (Executive)

Company: HARTFORD INSURANCE GROUP, INC. (HIG)

Report Date: 2026-04-06

Detailed Transactions and Holdings:

• Sold 3 shares of Common Stock at $136.19 per share (Direct)
  Date: 2026-04-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 624.98 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Restricted Stock Units (Direct)
  Date: 2026-04-06 | Code: H | shares_owned_after: 1,931.23
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-06 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 558.98 | Footnotes: F2

Footnotes:

• F1: Transaction involving a disposition to the Company of equity securities in satisfaction of tax withholding obligations in connection with a distribution to the reporting person of restricted stock units pursuant to The Hartford's 2025 Long Term Incentive Stock Plan.
• F2: This figure represents the reporting person's approximate share equivalent holdings in The Hartford Stock Fund (the "Fund") under the Company's 401(k) plan. The Fund consists of Company common stock (typically 99% of the Fund value) and short-term investments (typically less than 1% of the Fund value) and the number of share equivalents varies depending on the performance of the Company, the overall stock market, the amount of cash awaiting investment, and the performance and amount of short-term investments held by the Fund, less any expense accrued against the Fund. The number of shares attributed to the reporting person and expressed as share equivalents is based on information furnished by the 401(k) plan administrator as of April 2, 2026.